Guidelines for Submitting Adverse Event Reports for Publication-Reference-Cited by-同舟云学术

Guidelines for Submitting Adverse Event Reports for Publication

Published:2009-07 Issue:4 Volume:64 Page:289-294
ISSN:0040-5957
Container-title:Therapies
language:en
Short-container-title:Therapies

Author:

Kelly William,Arellano Felix,Barnes Joanne,Bergman Ulf,Edwards Ralph,Fernandez Alina,Freedman Stephen,Goldsmith David,Huang Kui,Jones Judith,McLeay Rachel,Moore Nicholas,Stather Rosie,Trenque Thierry,Troutman William,van Puijenbroek Eugène,Williams Frank,Wise Robert

Publisher

Elsevier BV

Subject

Pharmacology (medical)

Reference21 articles.

1. Informativity of adverse reactions data in medical publications;Venulet;Drug Inf J,1985

2. Addendum to guidelines for reporting adverse drug reactions;Cohen;Br Med J,1988

3. Anecdotes as evidence;Aronson;BMJ,2003

4. Guidelines for anecdotes might include more information;Abanades;BMJ,2003

5. BMJ paper styles. Drug points. http://bmj.bmjjournals.com/advice/sections.shtml.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Materiovigilance: An Overview;International Journal of Innovative Science and Research Technology (IJISRT);2024-07-11

2. CaReL Guideline: A Consensus-Based Guideline on Case Reports and Literature Review (CaReL);Barw Medical Journal;2024-06-23

3. Evaluation of a simplified pharmacovigilance tool for general practitioners: 5 years of insight;Scientific Reports;2024-01-20

4. Materiovigilance in Perspective: Understanding Its Concept and Practice in the Global Healthcare System;Therapeutic Innovation & Regulatory Science;2023-04-27

5. c4c: Paediatric pharmacovigilance: Methodological considerations in research and development of medicines for children – A c4c expert group white paper;British Journal of Clinical Pharmacology;2021-12-18